Book summary “The rise and fall of modern medicine”: summary

Introduction

You live with a strange paradox in modern healthcare. You spend more money and witness more medical technology than ever, yet you often feel that doctors understand your chronic ailments less and less.

James Le Fanu addresses this frustration by examining the historic peak of medical achievement between 1950 and 1980. You discover how doctors mastered infectious diseases and heart surgery through unexpected clinical observation rather than planned laboratory science.

The book traces how this golden age stalled. You learn how reductionist genetics, corporate drug design, and lifestyle dogma replaced traditional bedside diagnosis.

• Which accidental discoveries created the post-war therapeutic revolution?
• How did randomized trials change the standard of medical proof?
• Why did the momentum of medical discovery slow down after 1980?
• What must you do to restore clinical judgment to healthcare?

1. The Post-War Therapeutic Revolution

The golden age of modern medicine was driven by accidental discoveries of antibiotics and steroids rather than rational molecular design.

You enter an era where proven medical remedies grew from a dozen in the 1930s to over two thousand thirty years later. This therapeutic cornucopia emerged because chemists synthesized thousands of variations from accidental leads and industrial side effects. You discover that 30 drugs from the 1927 first edition of Cecil's Textbook of Medicine remained in use by the fourteenth edition.

Penicillin and Antibiotics

The discovery of penicillin was an improbable accident made possible by a rare combination of environmental and meteorological conditions rather than systematic scientific reasoning.

In July 1928, Alexander Fleming returned from holiday to find a Penicillium notatum spore from C. J. LaTouche's laboratory had floated onto an unincubated petri dish during a cold spell, dissolving nearby staphylococcus colonies. This replication required a rare strain from a downstairs laboratory, an exceptionally cool nine-day period in London in July 1928 at 20 degrees Celsius, and a subsequent temperature rise to 35 degrees Celsius.

While Fleming abandoned penicillin due to the belief that natural chemicals were too toxic, biochemist Ernst Chain and pathologist Howard Florey purified the substance, proved it was non-toxic, and demonstrated its curative effects on infected mice.

Florey and Chain divided ten streptococcus-infected mice into two groups, giving penicillin to five and a placebo to five, resulting in the survival of the penicillin-treated mice and the death of the placebo group.

On 12 February 1941, 43-year-old policeman Albert Alexander was treated with penicillin for septic scratches from a rose bush, experiencing a striking recovery before the drug ran out and he died a month later. Charles Fletcher administered penicillin every three hours to a severely ill patient with multiple septic abscesses. The patient showed dramatic initial improvement before supplies ran out, highlighting both the therapeutic potential and the desperate transition from human susceptibility to bacterial infection.

Cortisone and Steroids

Philip Hench discovered that cortisone could dramatically ameliorate rheumatoid arthritis by investigating natural remissions caused by jaundice and pregnancy.

On 26 September 1948, Dr Philip Hench administered 100mg daily of Compound E to 29-year-old Mrs Gardner, whose severe rheumatoid arthritis rapidly remitted, allowing her to walk with ease and shop downtown. Noticing that rheumatoid arthritis temporarily remitted during episodes of jaundice and pregnancy, Hench hypothesized the existence of a natural hormone called Substance X, which was eventually identified as Edward Kendall's adrenal compound E.

Cortisone revolutionized therapeutics by controlling the inflammatory response, revealing that many disparate diseases share the unifying feature of uncontrolled inflammation.

A single 1950 issue of the Bulletin of the Johns Hopkins Hospital featured four separate papers detailing successful cortisone treatments for chronic asthma, drug hypersensitivity, connective tissue disorders, and eye diseases. While cortisone does not cure the underlying causes of rheumatoid arthritis and carries severe side-effects like ulcers and bone crushing at high doses, it successfully orchestrates and suppresses damaging inflammatory responses across hundreds of illnesses.

2. Surgical Triumphs and Technological Marvels

Innovative surgical techniques and precision instruments enabled doctors to bypass natural barriers and perform complex operations on the heart, joints, and organs.

Open-Heart Surgery

The heart must constantly pump blood through the lungs and body. Surgery inside it required a mechanical bypass device. John Gibbon conceived this pump in 1931, using an air pump, glass and rubber tubing, and a rotating drum oxygenator to simulate the heart and lungs.

John Gibbon spent a night in 1931 monitoring a patient who died from a pulmonary embolus, sparking his idea for the pump. After years of testing on cats with his wife Mary, he performed his first successful human open-heart operation on an 18-year-old woman named Cecilia in May 1953.

The heart-lung machine transformed cardiac surgery during the five-year period from 1955 to 1960. Fallot's Tetralogy involves a narrowed pulmonary valve and a ventricular septal defect, causing deoxygenated blood to bypass the lungs and turning children blue and breathless. Untreated blue babies with Fallot's Tetralogy had a maximum lifespan of 10 years of age.

Dr. Helen Taussig proposed linking the aorta and pulmonary artery to route blue blood through the lungs, leading to the first successful Blalock-Taussig operation performed by Alfred Blalock in 1944. Surgeons performed 500 operations using the Blalock-Taussig method over the following two years. Treatment eventually progressed from this aorta-pulmonary artery shunt to closed pulmonary valvotomies and ultimately to open-heart repair.

Joint Replacements and Minimally Invasive Surgery

Replicating the hip joint requires balancing extreme weight-bearing with full mobility. John Charnley solved the complex mechanics of total hip replacement through three major innovations: ultra-low friction materials, acrylic cement fixation, and a reduced-diameter socket.

Charnley was inspired to investigate joint friction after a patient complained that his Judet artificial hip squeaked so loudly his wife avoided the room. He published his landmark paper in The Lancet in 1961, detailing a coefficient of friction of 0.005 found in a normal knee joint. He used acrylic cement as a grout to transfer loads rather than a glue, increasing the fixation of the femoral prosthesis by a factor of 200.

Early Teflon sockets wore away completely within years and caused severe inflammatory reactions that loosened the implants. Through a fortuitous introduction via a textile gear salesman, Charnley tested High Molecular Weight Polyethylene and found it possessed virtually zero wear and minimal tissue reaction.

Charnley tested the new plastic's biocompatibility by injecting a piece under his own skin alongside a Teflon specimen, discovering the polyethylene produced no palpable inflammatory nodule. Testing on a machine showed wear of 1/2000th of an inch on the HMWP test machine after two days. He gave the new hip to 500 patients over the subsequent three years, reporting an overall success rate of 92.7 per cent.

Technological developments like laparoscopy and coronary angioplasty enabled doctors to extend major procedures into the seventh, eighth, and ninth decades of life. Minimally invasive keyhole surgery and catheter-based procedures democratised medical interventions, allowing complex operations to be performed safely on much older patients.

Charles Dotter used a catheter to dilate a blocked femoral artery in an 82-year-old woman named Laura Shaw who had refused leg amputation, successfully healing her gangrenous toes in 1964. Andreas Gruentzig performed the first coronary angioplasty in 1977.

The German optics company Zeiss produced the first binocular surgical microscope in 1954. Harold Ridley successfully replaced cloudy cataracts with artificial plastic lenses in the eye, enduring severe peer skepticism before microscope technology improved success rates.

Harold Hopkins solved historical optical limitations by inventing the flexible fibreoptic endoscope and the high-transmission rod-lens system. Basil Hirschowitz collaborated with Larry Curtiss to melt glass rods inside tubes of lower refractive index, overcoming light loss and cross-talk to build the first modern fibreoptic gastroscope.

3. Statistics and the Standardization of Clinical Trials

The year 1950 acted as a historic watershed dividing medicine's past focus on infectious diseases from its future preoccupation with non-infectious chronic illnesses. For a century before 1950, the germ theory dominated medical research to find treatments for infectious diseases like tuberculosis. With the advent of antibiotics and the realization that social habits like smoking caused cancer, medicine shifted its focus to non-infectious conditions like cancer, strokes, and heart attacks, while statistics became the ultimate arbiter of scientific truth.

Austin Bradford Hill established medical statistics as the dominant arbiter of scientific truth by applying common sense to figures.

As Professor of Medical Statistics, Bradford Hill lacked formal statistical training and a medical degree, viewing his methods simply as common sense applied to figures. He built on the legacy of Major Greenwood and Karl Pearson to elevate statistical methods, which soon permeated every aspect of medicine. Bradford Hill contracted tuberculosis during World War I while serving as a naval pilot, was invalided home with a 100 per cent disability pension, and subsequently pursued a career in statistics, drawing his pension for 74 years until his death at age 93.

The Randomized Controlled Trial

The randomized controlled trial was established by Bradford Hill to objectively test drug efficacy and eliminate human bias. Faced with a severe shortage of streptomycin due to post-war dollar scarcity, Bradford Hill turned necessity into a virtue by designing the first randomized controlled trial. Using random numbers placed in sealed envelopes, patients were allocated to treatment or control groups to prevent personal bias and eliminate clinical subjectivity.

In the first streptomycin trial involving 55 treated patients and 52 controls, 28 treated patients showed marked improvement while 14 controls died, though subsequent follow-ups revealed bacterial resistance. Later, an 80 per cent survival rate was achieved when combining streptomycin with PAS.

You can design reliable evaluations by following specific allocation steps:

• Construct an order of allocation unknown in advance to the clinician, such as alternating orthodox and new treatments.
• Determine the allocation to treatment or control groups at random using a series of random numbers placed in sealed envelopes.

Causation and Smoking

Because almost everyone smoked after World War II, standard observation could not link smoking to cancer. Using case-control studies comparing lung cancer patients to hospital controls, followed by a prospective cohort study of 60,000 doctors, they demonstrated a clear dose-response relationship where heavier smoking exponentially increased lung cancer risk.

Richard Doll worked with lady almoners to interview hospital patients, finding that 99.7 per cent of lung cancer patients smoked, and later surveyed 40,000 doctors on the Medical Register. In 1950, 13,000 deaths from lung cancer occurred, exceeding tuberculosis for the first time. Individuals smoking 25 or more cigarettes a day faced a 25 times increased risk of lung cancer compared to non-smokers.

To prevent false inferences from lifestyle studies, Bradford Hill established internal coherence rules that require an association to be biologically plausible, strong, consistent, temporally parallel, dose-responsive, and confirmed by experiment. Bradford Hill applied these 6 core viewpoints and criteria to smoking and lung cancer, showing that tobacco contains cancer-inducing agents, displays a strong twenty-five-fold risk increase, shows a dose gradient, and yields reduced risk upon quitting.

You can evaluate potential causal links by checking specific criteria:

• Verify that the correlation between the environmental factor and the disease is biologically plausible.
• Check that the statistical correlation is strong in terms of relative risk.
• Confirm the presence of a biological gradient where higher exposure increases disease risk.
• Ensure the correlation is found consistently across multiple independent studies.
• Check that the correlation holds over time and parallels the rise in disease incidence.
• Confirm the association through experiment, such as observing if removing the exposure reduces risk.

4. The Fall of Modern Medicine and Future Prospects

The post-war momentum faltered due to reductionist genetics, lifestyle dogma, and pharmaceutical marketing, requiring a return to traditional clinical judgment.

The Social Theory and Genetics

Massive clinical trials launched in the 1970s to prove that reducing dietary fat would prevent heart disease ultimately failed to show any reduction in heart attacks. The Multiple Risk Factor Intervention Trial involved 12,000 high-risk men where participants reduced saturated fat by a quarter, yet their cholesterol fell by only 5 percent and heart attack rates remained unchanged.

The £100 million spent on major scientific experiments testing the lifestyle theory included interviewing 360,000 middle-aged American men for MRFIT. Another 50,000 men participated across 66 factories in the WHO Trial. Despite prodigious efforts to drastically alter diets and lifestyles, participants who lowered their saturated fat intake were no less likely to suffer heart attacks than the control groups.

Gene therapy aimed to cure single-gene disorders by inserting normal genes using disabled viral vectors, but clinical trials ultimately failed because the unidirectional model of gene action ignores the complex interactive network of the genome.

The first human gene therapy took place in 1990 for two girls with ADA deficiency using disabled viruses to carry normal genes into white blood cells, though patients also continued enzyme treatments. Direct enzyme preparation treatment for ADA deficiency cost £100,000 a year. Subsequent trials in 1995 for cystic fibrosis and Duchenne's muscular dystrophy failed to show clinical efficacy, with viral vectors proving ineffective at transferring genes into diseased cells.

In 1990, Cynthia Cutshall and Ashanthi de Silva became the first patients to undergo gene therapy for ADA deficiency at the US National Institute of Cancer. By 1995, NIH spending on gene therapy research reached $200 million a year. An internal NIH review and two New England Journal of Medicine papers concluded in 1995 that gene therapy was useless.

The fundamental flaw lies in treating genes like independent car parts. The genome functions like an interconnected spider's web or orchestra where multiple regulatory genes interact, rendering single-gene replacements ineffective.

As accidental drug discoveries dried up, drug companies resorted to promoting expensive or useless variations to maintain profitability. Because academic doctors rely on industry funds for research, their involvement compromises the independence of medical opinion and opinion leaders. The editor of The Lancet criticized academic medical heads spending two months a year traveling internationally at the behest of drug companies, noting that commercial involvement puts the independence of research at risk.

Restoring Clinical Wisdom

Medicine's true continuity lies not in progressive novelty but in the timeless virtues of clinical judgment, good sense, and the personal doctor-patient relationship. Sir William Osler emphasized that the core work of medicine—to prevent disease, relieve suffering, and heal the sick—has remained unbroken since Ancient Greece. Reaffirming the personal relationship between doctor and patient restores medicine to its true historical tradition spanning back 2,500 years to Ancient Greece and the Hippocratic school.

To address modern medical discontents, the profession must explicitly discard the intellectual falsehoods of The Social Theory and the reductionist pretensions of The New Genetics. The Social Theory has undermined medical authority through statistical sophistry and expert committees, while The New Genetics traps research in a reductionist blind alley centered solely on the gene. Clearing away these smokescreen illusions allows you to focus on legitimate tasks.

You can follow practical rules to restore clinical wisdom:

• Listen carefully to what the patient is being told.
• Perform the irreducible minimum of investigations necessary to establish a diagnosis.
• Confine oneself to the matter in hand without giving impudent or gratuitous advice.
• Recognize the intellectual limits of human understanding and the practical limits of what medicine can achieve.
• Recognize and discard error, following William Harvey's historical precedent.
• Institute an independent inquiry with a mandate to investigate how statistical sophistry and expert committees misled the public and profession over thirty years.

10 Key Ideas

1. The golden age of modern medicine was driven by accidental discoveries of antibiotics and steroids rather than rational molecular design.
2. Philip Hench discovered that cortisone could dramatically ameliorate rheumatoid arthritis by investigating natural remissions caused by jaundice and pregnancy.
3. Innovative surgical techniques and precision instruments enabled doctors to bypass natural barriers and perform complex operations on the heart, joints, and organs.
4. John Charnley solved the complex mechanics of total hip replacement through three major innovations: ultra-low friction materials, acrylic cement fixation, and a reduced-diameter socket.
5. Austin Bradford Hill established medical statistics as the dominant arbiter of scientific truth by applying common sense to figures.
6. Massive clinical trials launched in the 1970s to prove that reducing dietary fat would prevent heart disease ultimately failed to show any reduction in heart attacks.
7. Gene therapy aimed to cure single-gene disorders by inserting normal genes using disabled viral vectors, but clinical trials ultimately failed because the unidirectional model of gene action ignores the complex interactive network of the genome.
8. As accidental drug discoveries dried up, drug companies resorted to promoting expensive or useless variations to maintain profitability.
9. You live with a strange paradox in modern healthcare, spending more money and witnessing more medical technology while often feeling that doctors understand your chronic ailments less and less.
10. Medicine's true continuity lies not in progressive novelty but in the timeless virtues of clinical judgment, good sense, and the personal doctor-patient relationship.